AstraZeneca PLC

AstraZeneca: CHMP Recommends Lynparza And Imfinzi Combination For EU Approval In Endometrial Cancer

01 Jul 2024 03:09:21 By NASDAQ US Markets

Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN

28 Jun 2024 10:33:02 By NASDAQ Stocks

AstraZeneca: Imfinzi Trial Fails To Meet Endpoint In Early-stage Non-small Cell Lung Cancer

25 Jun 2024 03:08:02 By NASDAQ US Markets

AstraZeneca: Phase III Truqap Trial Plus Chemotherapy Fails To Meet Primary Goals In Breast Cancer

18 Jun 2024 03:15:21 By NASDAQ US Markets

AstraZeneca's Calquence Combo Cuts Progression Risk By 27% In Mantle Cell Lymphoma Trial

16 Jun 2024 12:33:03 By NASDAQ US Markets

FDA Approves AstraZeneca's Farxiga For Pediatric Use In Type-2 Diabetes

12 Jun 2024 21:53:19 By NASDAQ US Markets

NetDania - New 12 months High: AstraZeneca PLC

10 Jun 2024 03:21:31 By NetDania Notify

1 Biopharma Stock Setting the New Standard in Cancer Care Drugs

07 Jun 2024 12:13:02 By NASDAQ Stocks

Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference

05 Jun 2024 19:29:29 By Forbes - World

AstraZeneca Completes Acquisition Of Fusion Pharma

05 Jun 2024 03:08:45 By NASDAQ US Markets

CHMP Recommends Approval Of AstraZeneca's Tagrisso Combo For EGFR-Mutated Advanced Lung Cancer

03 Jun 2024 03:15:45 By NASDAQ US Markets

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

30 May 2024 05:59:20 By NASDAQ US Markets

AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock

29 May 2024 10:20:48 By NASDAQ US Markets

AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock?

29 May 2024 08:32:19 By NASDAQ US Markets

AZN:Datopotamab Deruxtecan Shows Favorable Survival Results, Falls Short Of Statistical Significance

27 May 2024 02:59:14 By NASDAQ US Markets

Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More

24 May 2024 10:30:58 By NASDAQ Stocks

NetDania - New 12 months High: AstraZeneca PLC

23 May 2024 10:35:27 By NetDania Notify

AstraZeneca Targets $80 Bln Revenue By 2030, Plans To Launch 20 New Medicines

21 May 2024 03:02:29 By NASDAQ US Markets

AstraZeneca To Build $1.5 Bln Manufacturing Facility In Singapore For Antibody Drug Conjugates

20 May 2024 02:42:36 By NASDAQ US Markets

AstraZeneca: New Data Shows Tezspire's Role In Future COPD Treatment

19 May 2024 22:05:22 By NASDAQ US Markets